21 Best Immunotherapy for prostate cancer Doctors in Istanbul

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Professor Sezer Sağlam is a senior medical oncologist at Gayrettepe Florence Nightingale Hospital, specialising in complex systemic therapies for advanced malignancies.

• Holds a professorship in medical oncology – the highest academic rank in the field
• Maintains active membership in the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Specialised in neuroendocrine tumours through the European Neuroendocrine Tumour Society (ENET)
• Fellowship trained at Istanbul University – Turkey's most prestigious medical institution

Professor Karaaslan leads systemic cancer treatments at Anadolu Medical Center, an institution affiliated with the world-renowned Johns Hopkins Medicine.

• Specialises in immunotherapy and targeted therapy for urogenital cancers
• Combines hormone therapy with modern systemic protocols for prostate cases
• Former oncology expert at the Gülhane Military Medical Academy
• Active member of the Turkish Medical Oncology Society
• Trained at Istanbul University’s prestigious medical faculties

Professor Mustafa Solak gained international expertise at the University of Texas MD Anderson Cancer Center, world-renowned for developing modern cancer protocols.

• Specialises in immunotherapy with Keytruda for advanced prostate malignancies
• Completed an advanced oncology fellowship at the Hacettepe University Cancer Institute
• Integrates hormone therapy and targeted treatments for systemic cancer care
• Treats complex solid tumours at Hisar Hospital Intercontinental in Istanbul
• Expertise includes managing side effects of modern biological therapies

Professor Yesim Yildirim is an ESMO-certified medical oncologist at Anadolu Medical Center who completed specialised immuno-oncology training at the Mount Vernon Cancer Centre in the UK.

• Specialises in immunotherapy and targeted treatments for malignant tumours
• Founded the Turkish Gastrointestinal Oncology Network to improve patient care standards
• Published over 80 scientific works focusing on precision medicine and advanced cancer care
• Member of the American Society of Clinical Oncology (ASCO)

Associate Professor Heves Surmeli is a leading medical oncologist at Hisar Hospital Intercontinental who recently served as the Clinical Director at Istanbul's Kartal Dr Lütfi Kırdar Hospital.

• Specialises in urological cancers including immunotherapy protocols for prostate cases
• Completed subspecialty fellowship training in Medical Oncology
• Published extensive research in international peer-reviewed journals on oncology outcomes
• Active member of several professional medical oncology societies
• Recognised with multiple academic awards for her clinical contributions

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Associate Professor Eda Tanrıkulu Şimşek ranked 3rd nationwide in Turkey's medical specialty exams and leads international clinical trials for new cancer therapies.

• Specialises in matching immunotherapy and targeted treatments to a tumour's specific genetic profile
• Former Head of Medical Oncology at Haydarpaşa Numune Training and Research Hospital
• Completed advanced oncology training at Oxford University and The Christie in Manchester
• Active member of the European Society for Medical Oncology and ASCO
• Uses personalised protocols for complex urological and gastrointestinal cancers

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Professor Cemil Bilir is a leading medical oncologist specialising in molecular oncology and the latest immunotherapy protocols for urological cancers.

• Completed a research fellowship at Northeastern University's Center for Pharmaceutical Biotechnology and Nanomedicine in Boston
• Serves as a Professor at Sakarya University Faculty of Medicine – one of Turkey's established medical schools
• Active member of the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO)
• Participates in international clinical trials to provide patients with emerging cancer therapies

Associate Professor Muhammed Mustafa Atci is a highly regarded medical oncologist at İstinye University Liv Hospital Topkapı, where he specialises in advanced cancer protocols.

• Holds a dual specialty in internal medicine and medical oncology with a focus on modern targeted therapies
• Acts as an Education Coordinator, training the next generation of oncology specialists in Turkey
• Active member of the American Society of Clinical Oncology (ASCO) since 2018
• Extensively published in peer-reviewed international journals on tumour biomarkers and survival outcomes

Professor Irfan Cicin is a senior medical oncologist who leads the oncology department at Trakya University Faculty of Medicine. He specialises in systemic treatments for complex urological cancers at İstinye University Liv Hospital Topkapı.

• Holds a full professorship in oncology, training the next generation of cancer specialists
• Completed senior fellowship training in medical oncology at Trakya University
• Published extensive research on medical oncology protocols and internal medicine
• Member of the Turkish Society of Medical Oncology

Professor Ozden is a medical oncology specialist at VM Medical Park Pendik Hospital who focuses on precision-based protocols for prostate and gastrointestinal malignancies.

• Specialises in immunotherapy agents like Keytruda to help the immune system target cancer cells
• Uses PET-MRI and PET-CT imaging to ensure accurate staging for advanced prostate cases
• Integrates targeted therapy to identify and attack specific cancer cell markers
• Internal medicine background helps him manage side effects during complex treatment cycles
• Trained at Istanbul University Cerrahpaşa Faculty of Medicine – a premier Turkish medical school

Associate Professor Nail Paksoy is a dual-certified specialist in both immunology and medical oncology, offering a unique perspective on immunotherapy treatments. He currently serves at Medipol Bahcelievler University Hospital in Istanbul.

• Holds ESMO Board Certification in Medical Oncology from Paris
• Completed a dedicated fellowship in Allergy and Immunology
• Published research on PSMA-based tumour burden and immunotherapy outcomes
• Serves as a sub-investigator for major international clinical trials with Roche and MSD

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acibadem District Hospital, specialising in the complex field of targeted therapies and immunotherapy.

• Editorial board member for BMC Cancer, a prestigious international peer-reviewed journal
• Published over 50 scientific articles on solid tumours and advanced cancer care
• Expertise in geriatric oncology, focusing on treatment for older cancer patients
• Member of the European Society for Medical Oncology (ESMO)
• Completed clinical observership at the University of Leicester in the United Kingdom

Associate Professor Ayse Irem Yasin is a certified European Society for Medical Oncology (ESMO) specialist with extensive international training from Cleveland Clinic and Harvard Medical School.

• Specialises in urological cancers, focusing on the latest immunotherapy protocols for prostate malignancy
• Holds the prestigious ESMO Board Certificate, a globally recognised mark of oncological excellence
• Completed advanced observerships at major clinical centres in Switzerland, Italy, and the USA
• Former specialist at Sisli Etfal Training and Research Hospital, managing high-volume cancer cases

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Associate Professor Abdullah Sakin is a leading medical oncologist at Medipol Bahçelievler University Hospital. He specialises in systemic therapies for complex solid tumours and reproductive system cancers.

• Former Head of Medical Oncology at Yüzüncü Yıl University Faculty of Medicine
• Uses immunotherapy agents like Keytruda to treat advanced malignancies
• Combines molecular targeted biological therapies with hormone therapy for prostate care
• Served as an Education Officer training specialists at Prof Dr Cemil Taşçıoğlu City Hospital
• Highly published in research regarding digestive and respiratory system oncology